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1. Introduction 
Cahnodulin, which was originally described as an 
activator of cyclic nucleotide phosphodiesterase (EC 
3.1.4.17) [ 1,2], has been shown to mediate the Ca2+- 
dependent reactions including activation of several 
Ca2+-dependent enzymes and demonstrated in various 
eukaryotes [3-51. The activation mechanism of Ca’+- 
dependent enzymes by calmodulin involves the bind- 
ing of Ca2+ to calmodulin followed by the association 
of the enzyme with the Ca2+ .calmodulin complex 
[3-51. Inhibitor proteins of Ca2+-dependent phospho- 
diesterase have been reported in mammalian tissues, 
and one type of them is heat-stable [6-l 21. The inhib- 
itor proteins inhibit the Ca2+ . calmodulin-activated 
phosphodiesterase by forming a complex of inhib- 
itor . Ca2+ . calmodulin [6-l 71. Namely, the inhibitor 
proteins are considered to be a kind of calmodulin- 
binding protein. Furthermore, other kind of calmo- 
dulin-binding proteins have also been reported, which 
functions should be resolved, in various mammalian 
tissues [ 13-171. In other than mammalian tissues, 
there has been no report concerning a calmodulin- 
binding protein. We have found calmodulin-like activ- 
ity and a Ca2+-dependent phosphodiesterase, which 
is not sensitive to calmodulin, in the soluble fraction 
ofEscherichia coli [ 18 ,191. During the course of these 
studies, a heat-stable and trypsinsensitive inhibitory 
factor for bovine brain phosphodiesterase has been 
found in E. coli. Here, the inhibitory factor was par- 
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tially purified and its physicochemical natures and 
the mechanism of action in mammalian phospho- 
diesterase reaction were examined. The results indi- 
cate that the inhibitory factor is a protein and com- 
bines with calmodulin in the presence of Ca’+, thereby 
causing an inhibition of phosphodiesterase reaction. 
The inhibitory factor is tentatively referred to here- 
after as the inhibitor protein. 
2. Materials and methods 
A strain of E. coli (O-143, K-Xl) was employed. 
Calmodulin and calmodulindeficient phosphodi- 
esterase were prepared from bovine brain by the meth- 
ods in [20] and [8], respectively. Ca2+-Dependent 
phosphodiesterase of E. coli was purified as in [ 191. 
Calmodulin-agarose affinity column was prepared 
by the method in [8] employing 18 mg bovine brain 
calmodulin and 60 ml Sepharose 4B (Pharmacia). 
Croralus atrox venom (5’-nucleotidase), cyclic AMP, 
bovine serum albumin, horse heart cytochrome c, 
trypsin, soybean trypsin inhibitor, DNase, RNase 
and lysozyme were obtained from Sigma. Ovalbumin 
(twice crystallized) was a product of Nutritional Bio- 
chemicals. Other chemicals were obtained from com- 
mercial sources. 
The inhibitor protein was assayed by its inhibitory 
activity against Ca2+ . calmodulin-activated phospho- 
diesterase of bovine brain. Prior to assay, the sample 
was heated for 5 min in a boiling water bath to destroy 
the endogenous phosphodiesterase activity. The reac- 
tion mixture (0.5 ml) contained 40 pmol imidazole- 
HCl (pH 6.9), 1.5 pmol MgS04, 150 ~01 dithiothrei- 
tol, 500 I.cg bovine serum albumin, 400 nmol cyclic 
AMP, 500 nmol CaC12 or 2.5 ~01 EGTA, 51 tig 
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bovine brain calmodulindeficient phosphodiesterase, 
0.33 pg brain calmodulin and the inhibitor protein 
preparation. The assay was done as in [ 1l.E. coli phos- 
phodiesterase was assayed under the same conditions 
except that instead of brain phosphodiesterase and 
calmodulin, 113 pg E. coli phosphodiesterase was 
employed. Protein was determined as in [21]. TheMr- 
value of the inhibitor protein was estimated by gel 
filtration on a Sephadex G-100 column (2.5 X 90 cm) 
as in [22]. The proteins used as standards were bovine 
serum albumin (M, 67 500) ovalbumin (M, 45 000) 
soybean trypsin inhibitor (M, 2 1 600) and horse heart 
cytochrome c (M, 12 400). 
3. Results and discussion 
Wet cells (20 g), which were grown aerobically in 
a nutrient broth and harvested at late logarithmic 
phase, were sonicated for 5 min with 2 vol. buffer A 
(20 mM Tris-HCl (pH 7.5), 10 mM 2-mercapto- 
ethanol, 1 mM imidazole, 1 mM magnesium acetate, 
0.1 mM EGTA and 0.43 mM phenylmethylsulfonyl- 
fluoride). The homogenate was centrifuged for 20 min 
at 35 000 X g. To the supematant (1634 mg protein) 
was added a saturated ammonium sulfate solution 
(pH 7.5) to a final saturation of 55%. The supernatant 
was dialyzed against 50 vol. buffer A containing 0.2 M 
NaCl with 3 changes. The sample (356 mg protein) 
was applied to a DEAE-cellulose (DE-52) column 
(2.4 X 15 cm) equilibrated with the buffer. After the 
column was washed with 150 ml buffer, the inhibitor 
protein was eluted by a 300 ml linear concentration 
gradient of NaCl (0.2-0.5 M) in buffer A. Fractions 
3 ml each were collected. When each fraction of the 
chromatography was heated and then assayed for 
inhibitor activity against the Ca2+ . calmodulin-acti- 
vated phosphodiesterase of bovine brain, a single 
peak of inhibitory activity appeared in the fractions 
35-65, as shown in fig.1. These fractions were pooled 
and concentrated to 12 ml by an Amicon ultrafiltra- 
tion cell equipped with PM-10 filter. The sample was 
centrifuged at 100 000 X g for 30 min. The super- 
natant (30 mg protein) was subjected to gel filtration 
on a Sephadex G-l 00 column (2.5 X 90 cm) equili- 
brated with buffer A containing 0.1 M NaCl and 10% 
sucrose. Elution was performed with the buffer. Frac- 
tions 3.3 ml each were collected. The inhibitory activ- 
ity showed a symmetrical peak on the gel filtration, 
and the Mr-value was calculated to be -30 000 (not 
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Fig.1. Resolution of heat-stable inhibitor protein on DEAE- 
cellulose column chromatography employing linear concen- 
tration gradient of NaCl (---). Detailed experimental con- 
ditions are described in the text. A 0.35 ml aliquot of each 
fraction was boiled for 5 mm and then assayed for its inhib- 
itory activity against Ca’+ . cahnodulinactivated bovine brain 
phosphodiesterase under the standard conditions in section 2 
except that 25.5 c(g phosphodiesterase was employed. The 
enzyme activity in the presence of 1 mM CaCI, is indicated 
by closed circle. 
shown). Active fractions were pooled and concentrated 
by the ultrafdtration to 2 ml (7.1 mg protein). This 
purified inhibitory factor was employed for the follow- 
ing studies. To examine the chemical nature of the 
inhibitory factor, the purified sample was preincu- 
bated with various enzymes. The heat-stable inhibitory 
factor appeared to be a protein since its activity was 
readily destroyed upon preincubation with trypsin 
and not with other enzymes such as DNase, RNase 
and lysozyme (table 1). As shown in fig.2, the inhibitor 
protein appeared to inhibit the phosphodiesterase of 
bovine brain in the presence of both Ca2+ and calmod- 
ulin, and increasing the amount of the inhibitor pro- 
tein resulted in increased inhibition of the reaction. 
The rate of the maximally inhibited reaction ap- 
proached that of the basal activity of the enzyme in 
the presence of EGTA. The enzyme activity in the 
absence of Ca2+ (Ca’+ was chelated with EGTA) was 
not affected by the inhibitor protein. A calmodulin- 
independent enzyme, Ca2+-dependent phosphodiester- 
ase of E. coli was not also inhibited by the inhibitor 
protein. Moreover, an increase in the reaction mixture 
of Ca2+ from 0.1-2 mM did not affect the inhibition 
of brain phosphodiesterase by the inhibitor protein 
(not shown). However, high concentration of calmod- 
ulin could reverse the inhibition of brain phosphodi- 
esterase by the inhibitor protein. Fig.3 shows the effect 
of the inhibitor protein on the dose-response curve 
Volume 128, number 2 FEBS LETTERS June 1981 
Table 1 
Nature of the inhibitory factor from E. coli 
Additions Treatment of 
inhibitor 
Phosphodiesterase 
activity (A,,,) 
None 
Inhibitor 
Inhibitor 
Inhibitor 
Inhibitor 
Inhibitor 
Inhibitor 
Inhibitor 
Inhibitor 
None 
Boiled for 2 min 
Boiled for 5 min 
Boiled for 10 min 
Trypsin 
RNase 
DNase 
Lysozyme 
0.467 
0.042 
0.049 
0.049 
0.046 
0.411 
0.035 
0.045 
0.040 
The inhibitory factor (25.6 pg protein) was preincubated in 
the presence of 50 mM Tris-HCl @H 7.5), 1mM MgCl, and 
where indicated, trypsin (1 mg/ml), RNase (5 mg/ml) or lyso- 
zyme (5 mg/ml), in a total volume of 0.2 ml, for 60 min at 
30°C. Trypsin inhibitor (soybean) was then added at a final 
concentration of 1.2 mg/ml to the trypsin-treated sample. 
The inhibitory factor remaining after these treatments was 
assayed for its ability to inhibit the activity of bovine brain 
phosphodiesterase (25.5 pg) supported by brain calmodulin 
(0.45 pg) and 1 mM CaCI, under the standard conditions in 
section 2 
of the activation of brain phosphodiesterase by cal- 
modulin. In the presence of the inhibtor protein, the 
dose-response curve for the enzyme shifted to the 
right. The amount of calmodulin required to give half- 
maximal activation of the enzyme increased from 
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Fig.2. Effect of the inhibitor protein on the activities of bovine 
brain and E. coli phosphodiesterases. Phosphodiesterases were 
assayed under the standard conditions in the presence of 
various concentrations of the inhibitor protein as indicated. 
Circles and triangles indicate bovine brain and E. coli phos- 
phodiesterase activities, respectively, in the presence of 1 mM 
CaCl, (*,A) or 5 mM EGTA (~,a). 
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Fig.3. Effect of calmodulin concentration on the inhibition 
of bovine brain phosphodiesterase by the inhibitor protein. 
Phosphodiesterase activity in the presence (0) and absence 
(o) of 1.36 pg inhibitor protein was assayed at various con- 
centrations of calmodulin indicated. 
45-170 ng. With a maximum amount of calmodulin, 
the final activities in the enzyme system were compar- 
able whether the inhibitor protein was present or not. 
Fig.4 shows the formation of the inhibitor protein . 
calmodulin complex in the presence of Ca*+. The 
inhibitor protein was applied to a calmodulin-agarose 
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Fig.4. Ca’+dependent formation of the inhibitor protein . 
calmodulin complex in a calmodulin-agarose affinity column. 
The inhibitor protein (1.8 mg) was applied to a calmQdulin- 
coupled Sepharose 4B column (2 X 16 cm) equilibrated with 
buffer A containing 1 mM CaCl,. After the column was washed 
by a 60 ml buffer A containing 1 mM CaCl, and 0.2 M NaCI, 
as indicated by the arrow, the elution buffer was changed to 
buffer A containing 5 mM EGTA and 0.2 M NaCI. Fractions 
4 ml each were collected. A 0.35 ml aliquot of each fraction 
was assayed for the inhibitor activity under the standard con- 
ditions except that instead of 1 mM CaCl,, 5 mM CaCl, was 
employed. 
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affinity column. In the presence of Ca’+, the inhibitor 
protein was retained by the column. When the column 
was washed with a buffer containing EGTA, the inhib- 
itor protein was promptly released from the column. 
This experiment indicated that in the presence of Ca*+, 
the inhibitor protein interacted with calmodulin to form 
the inhibitor protein . calmodulin complex, and that ’ 
chelating Ca*+ with EGTA dissociated the complex 
into its two components. 
These results indicate that the inhibitor protein 
inhibits the activity of bovine brain phosphodiester- 
ase supported by calmodulin with forming the inhib- 
itor protein . calmodulin . Ca*+ complex. The purified 
inhibitor protein had no activity of phosphodiesterase 
or myosin light chain kinase, but it is plausible that 
the protein is another Ca*+ . calmodulin-dependent 
enzyme. Although the exact physiological function of 
this protein remains unknown at this time, it is clear 
that the inhibitor protein is a reaction site of calmod- 
ulin in E. coli. Further extensive studies are now in 
progress to obtain more detailed information regarding 
physicochemical properties and physiological signifi- 
cance of the inhibitor protein in E. coli. 
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